Our investigation into the correlation between TUBA1B expression and tumor stages revealed that TUBA1B levels increased with advancing stages in ACC, LIHC, and LUAD, suggesting the potential of TUBA1B as a prognostic marker in these tumors (Fig. 2A–C). This evidence concerns the gene TUBA1B and adrenal cortex carcinoma.